UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expression of genes potentially involved in loss of response in patients with chronic myeloid leukemia

Gene, 2024-02, Vol.896, p.148047-148047, Article 148047

2024

Volltextzugriff (PDF)

An unusual translocation, t(1;11)(q21;q23), in a case of chronic myeloid leukemia with a cryptic Philadelphia chromosome

Oncology letters, 2017-05, Vol.13 (5), p.3159-3162

2017

Volltextzugriff (PDF)

Partial and total monosomal karyotypes in myelodysplastic syndromes: Comparative prognostic relevance among 421 patients

American journal of hematology, 2011-07, Vol.86 (7), p.540-545

2011

Volltextzugriff (PDF)

Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in Argentinean patients

Annals of hematology, 2014-04, Vol.93 (4), p.705-707

2014

Volltextzugriff (PDF)

Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy

Blood cells, molecules, & diseases, 2014-02, Vol.52 (2-3), p.121-125

2014

Volltextzugriff (PDF)

The presence of -308A TNFα is associated with anemia and thrombocytopenia in patients with myelodysplastic syndromes

Blood cells, molecules, & diseases, 2011-12, Vol.47 (4), p.255-258

2011

Volltextzugriff (PDF)

GSTM1 and GSTP1 , but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response

Cancer epidemiology, 2016-10, Vol.44, p.16-21

2016

Volltextzugriff (PDF)

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Blood, 2013-05, Vol.121 (22), p.4439-4442

2013

Volltextzugriff (PDF)

TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome

Blood cells, molecules, & diseases, 2016-07, Vol.59, p.129-133

2016

Volltextzugriff (PDF)

Prognostic relevance of cytogenetic systems in myelodysplastic syndromes

Leukemia & lymphoma, 2012-08, Vol.53 (8), p.1640-1642

2012

Volltextzugriff (PDF)

CAMKIIγ, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease

Leukemia & lymphoma, 2014-09, Vol.55 (9), p.2101-2108

2014

Volltextzugriff (PDF)

Polymorphisms in TNF and IFNG are associated with clinical characteristics of aplastic anemia in Argentinean population

Leukemia & lymphoma, 2015-06, Vol.56 (6), p.1793-1798

2015

Volltextzugriff (PDF)

Real World Efficacy Evaluation of Branded and Copy Imatinib in Chronic Myeloid Leukemia: A Retrospective Multicentric Study from Argentina

Blood, 2020-11, Vol.136 (Supplement 1), p.36-37

2020

Volltextzugriff (PDF)

Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation

European journal of haematology, 2015-03, Vol.94 (3), p.270-272

2015

Volltextzugriff (PDF)

Early detection and quantification of mutations in the tyrosine kinase domain of chimerical BCR-ABL1 gene combining high-resolution melting analysis and mutant-allele specific quantitative polymerase chain reaction

Leukemia & lymphoma, 2013-03, Vol.54 (3), p.598-606

2013

Volltextzugriff (PDF)

Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR-ABL kinase domain mutations affect patient survival? First multicenter Argentinean study

Leukemia & lymphoma, 2011-09, Vol.52 (9), p.1720-1726

2011

Volltextzugriff (PDF)

Exploring the Significance of TP53, ABCB1 and GST Polymorphisms on Susceptibility and Pharmacogenetics in Argentinian Patients with Chronic Myeloid Leukemia

Blood, 2015-12, Vol.126 (23), p.5134-5134

2015

Volltextzugriff (PDF)

Expression of CAMKIIγ, HSP70 and HSP90 Genes Are Differentially Associated with the Mutational Status of Tirosine Kinase Domain in Chronic Myeloid Leukemia Resistant Patients

Blood, 2011-11, Vol.118 (21), p.4877-4877

2011

Volltextzugriff (PDF)

Daily Practice Experience in Ponatinib Treatment of Chronic Myeloid Leukemia (CML) Patients Resistant to Other Tyrosin Kynase Inhibitors (TKIs) in Argentina

Blood, 2015-12, Vol.126 (23), p.5149-5149

2015

Volltextzugriff (PDF)

Specific assessment of BCR–ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients

European journal of haematology, 2009-04, Vol.82 (4), p.292-300

2009

Volltextzugriff (PDF)

BAX/ BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia

Blood cells, molecules, & diseases, 2010-10, Vol.45 (3), p.192-196

2010

Volltextzugriff (PDF)

Argentine Registry of Hematologic Disease (RAEH) Chronics Myeloid Leukemia

Blood, 2011-11, Vol.118 (21), p.4455-4455

2011

Volltextzugriff (PDF)

Overall Survival by Prognosis Score in High-Risk Myelodysplastic Syndromes (MDS) Patients Receiving Decitabine Treatment: Results From Clinical Experience

Blood, 2011-11, Vol.118 (21), p.5024-5024

2011

Volltextzugriff (PDF)

Cytogenetic Features and Prognosis In Argentinean Patients with Myelodysplastic Syndrome: a Multicenter Study

Blood, 2010-11, Vol.116 (21), p.1888-1888

2010

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(46)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Hematology
(20)
Male
(19)
Female
(18)
Middle Aged
(16)
Aged
(15)
Adult
(14)
Oncology
(12)
Chronic Myeloid Leukemia
(10)
Aged, 80 And Over
(9)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(9)
Fusion Proteins, Bcr-Abl - Genetics
(8)
Young Adult
(8)
Adolescent
(7)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(7)
Prognosis
(6)
Treatment Outcome
(6)
Antineoplastic Agents - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expression of genes potentially involved in loss of response in patients with chronic myeloid leukemia

An unusual translocation, t(1;11)(q21;q23), in a case of chronic myeloid leukemia with a cryptic Philadelphia chromosome

Partial and total monosomal karyotypes in myelodysplastic syndromes: Comparative prognostic relevance among 421 patients

Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in Argentinean patients

Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy

The presence of -308A TNFα is associated with anemia and thrombocytopenia in patients with myelodysplastic syndromes

GSTM1 and GSTP1 , but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome

Prognostic relevance of cytogenetic systems in myelodysplastic syndromes

CAMKIIγ, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease

Polymorphisms in TNF and IFNG are associated with clinical characteristics of aplastic anemia in Argentinean population

Real World Efficacy Evaluation of Branded and Copy Imatinib in Chronic Myeloid Leukemia: A Retrospective Multicentric Study from Argentina

Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation

Early detection and quantification of mutations in the tyrosine kinase domain of chimerical BCR-ABL1 gene combining high-resolution melting analysis and mutant-allele specific quantitative polymerase chain reaction

Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR-ABL kinase domain mutations affect patient survival? First multicenter Argentinean study

BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival

Exploring the Significance of TP53, ABCB1 and GST Polymorphisms on Susceptibility and Pharmacogenetics in Argentinian Patients with Chronic Myeloid Leukemia

Expression of CAMKIIγ, HSP70 and HSP90 Genes Are Differentially Associated with the Mutational Status of Tirosine Kinase Domain in Chronic Myeloid Leukemia Resistant Patients

Daily Practice Experience in Ponatinib Treatment of Chronic Myeloid Leukemia (CML) Patients Resistant to Other Tyrosin Kynase Inhibitors (TKIs) in Argentina

Specific assessment of BCR–ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients

BAX/ BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia

Argentine Registry of Hematologic Disease (RAEH) Chronics Myeloid Leukemia

Overall Survival by Prognosis Score in High-Risk Myelodysplastic Syndromes (MDS) Patients Receiving Decitabine Treatment: Results From Clinical Experience

Cytogenetic Features and Prognosis In Argentinean Patients with Myelodysplastic Syndrome: a Multicenter Study

Suchergebnisse filtern